<VariationArchive VariationID="1188831" VariationName="NM_001197104.2(KMT2A):c.152_186del (p.Pro51fs)" VariationType="Deletion" Accession="VCV001188831" Version="6" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-07-29" DateCreated="2021-08-07" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1178838" VariationID="1188831">
      <GeneList>
        <Gene Symbol="KMT2A" FullName="lysine methyltransferase 2A" GeneID="4297" HGNC_ID="HGNC:7132" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118436492" stop="118526832" display_start="118436492" display_stop="118526832" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118307204" stop="118397538" display_start="118307204" display_stop="118397538" Strand="+" />
          </Location>
          <OMIM>159555</OMIM>
          <Haploinsufficiency last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-05-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KMT2A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001197104.2(KMT2A):c.152_186del (p.Pro51fs)</Name>
      <CanonicalSPDI>NC_000011.10:118436654:GTGGCGGCCCCGGGGCGCCCCCCTCCCCCCCGGCTGTGGCGGCC:GTGGCGGCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118436655" stop="118436689" display_start="118436655" display_stop="118436689" variantLength="35" positionVCF="118436654" referenceAlleleVCF="GGTGGCGGCCCCGGGGCGCCCCCCTCCCCCCCGGCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118307370" stop="118307404" display_start="118307370" display_stop="118307404" variantLength="35" positionVCF="118307369" referenceAlleleVCF="GGTGGCGGCCCCGGGGCGCCCCCCTCCCCCCCGGCT" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>P51fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.118436664_118436698del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.118436664_118436698del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.118307379_118307413del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.118307379_118307413del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027813.1" sequenceAccession="NG_027813" sequenceVersion="1" change="g.5175_5209del">
            <Expression>NG_027813.1:g.5175_5209del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001197104.2" sequenceAccession="NM_001197104" sequenceVersion="2" change="c.152_186del" MANESelect="true">
            <Expression>NM_001197104.2:c.152_186del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001184033.1" sequenceAccession="NP_001184033" sequenceVersion="1" change="p.Pro51fs">
            <Expression>NP_001184033.1:p.Pro51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005933.4" sequenceAccession="NM_005933" sequenceVersion="4" change="c.152_186del">
            <Expression>NM_005933.4:c.152_186del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005924.2" sequenceAccession="NP_005924" sequenceVersion="2" change="p.Pro51fs">
            <Expression>NP_005924.2:p.Pro51fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_613" sequenceAccession="LRG_613">
            <Expression>LRG_613:g.5175_5209del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_613t1" sequenceAccession="LRG_613t1">
            <Expression>LRG_613t1:c.152_186del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001197104.1" sequenceAccession="NM_001197104" sequenceVersion="1" change="c.152_186delCCGGGGCGCCCCCCTCCCCCCCGGCTGTGGCGGCC">
            <Expression>NM_001197104.1:c.152_186delCCGGGGCGCCCCCCTCCCCCCCGGCTGTGGCGGCC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2134153013" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001197104.2(KMT2A):c.152_186del (p.Pro51fs) AND Wiedemann-Steiner syndrome" Accession="RCV001548758" Version="1">
        <ClassifiedConditionList TraitSetID="8851">
          <ClassifiedCondition DB="MedGen" ID="C1854630">Wiedemann-Steiner syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-02-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001197104.2(KMT2A):c.152_186del (p.Pro51fs) AND not provided" Accession="RCV001559985" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001197104.2(KMT2A):c.152_186del (p.Pro51fs) AND KMT2A-related disorder" Accession="RCV003900790" Version="1">
        <ClassifiedConditionList TraitSetID="89110">
          <ClassifiedCondition>KMT2A-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-04" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2021-08-07" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="89110" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70731" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">KMT2A-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">KMT2A-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="8851" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5217" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Growth deficiency and mental retardation with facial dysmorphism</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiedemann-Steiner syndrome</ElementValue>
                <XRef ID="MONDO:0011518" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">WDSTS</ElementValue>
                <XRef Type="MIM" ID="605130" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Wiedemann-Steiner syndrome (WSS) is characterized by developmental delay, intellectual disability, and characteristic facial features, with or without additional congenital anomalies. The facial features include thick eyebrows with lateral flare, vertically narrow and downslanted palpebral fissures, widely spaced eyes, long eyelashes, wide nasal bridge, broad nasal tip, thin vermilion of the upper lip, and thick scalp hair. About 60% of affected individuals have hypertrichosis cubiti ("hairy elbows"), which was once thought to be pathognomic for the syndrome, with a majority having hypertrichosis of other body parts. Other clinical features include feeding difficulties, prenatal and postnatal growth restriction, epilepsy, ophthalmologic anomalies, congenital heart defects, hand anomalies (such as brachydactyly and clinodactyly), hypotonia, vertebral anomalies (especially fusion anomalies of the cervical spine), renal and uterine anomalies, immune dysfunction, brain malformations, and dental anomalies.</Attribute>
                <XRef ID="NBK580718" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5565" />
                <XRef ID="5565" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35617449</ID>
                <ID Source="BookShelf">NBK580718</ID>
              </Citation>
              <XRef ID="319182" DB="Orphanet" />
              <XRef ID="C1854630" DB="MedGen" />
              <XRef ID="MONDO:0011518" DB="MONDO" />
              <XRef Type="MIM" ID="605130" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3473499" SubmissionDate="2021-07-15" DateLastUpdated="2021-08-07" DateCreated="2021-08-07">
        <ClinVarSubmissionID localKey="NC_000011.9:g.118307379_118307413del35|OMIM:605130" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001768720" DateUpdated="2021-08-07" DateCreated="2021-08-07" Type="SCV" Version="1" SubmitterName="Gene Discovery Core-Manton Center, Boston Children's Hospital" OrgID="505675" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-02-14">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is interpretted as Pathogenic for Wiedemann-Steiner Syndrome (WSS); Autosomal Dominant. PVS1 - null variant (nonsense, frameshift, canonical splice sites, initiation codon, single or multiexon deletion) in a gene where LOF is a known mechanism of disease. PS2 - De novo (both maternity and paternity confirmed) in a patient with the disease and no family history. PM2 - Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PP5 - Reputable source recently reports variant as pathogenic, but the evidence is not available to the laboratory to perform an independent evaluation (PMID: 26633542).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.118307379_118307413del35</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605130" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10009842</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3501990" SubmissionDate="2022-01-05" DateLastUpdated="2023-03-04" DateCreated="2021-08-14">
        <ClinVarSubmissionID localKey="GDXSV:218994" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV001782314" DateUpdated="2023-03-04" DateCreated="2021-08-14" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (Lek et al., 2016); This variant is associated with the following publications: (PMID: 26633542, 28359930)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2A" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:39365</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001197104.1:c.152_186del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_22_20210812085049</SubmissionName>
          <SubmissionName>GeneDX_Clinvar_Submission_79_20220105054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8796616" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="39106613|KMT2A-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004709385" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The KMT2A c.152_186del35 variant is predicted to result in a frameshift and premature protein termination (p.Pro51Argfs*84). This variant has been reported in multiple individuals with Wiedemann-Steiner syndrome, and in at least one occurrence was reported as de novo (Table S3 in Retterer et al. 2016. PubMed ID: 26633542; Aggarwal et al. 2017. PubMed ID: 28359930). This variant has not been reported in a large population database, indicating this variant is rare. Frameshift variants in KMT2A are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KMT2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001197104.1:c.152_186del35</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">KMT2A-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8796616" TraitType="Disease" MappingType="Name" MappingValue="KMT2A-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="KMT2A-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3501990" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3473499" TraitType="Disease" MappingType="XRef" MappingValue="605130" MappingRef="OMIM">
        <MedGen CUI="C1854630" Name="Wiedemann-Steiner syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

